Value Growth Investors Should Do This With Salesforce
Salesforce just staged one of its biggest single-session rallies in years, but the real question is whether that move already priced in everything the AI story has to offer or left something on the table for investors willing to be…
At $252.05, Salesforce (NYSE:CRM | CRM Price Prediction) screens as an attractive setup for value-growth investors willing to average in after a violent post-earnings repricing. The stock just jumped 22.58% in a single session on a blowout print, forcing a real decision on whether the AI story is finally catching up to the fundamentals.
Salesforce is the world’s largest CRM software vendor, wrapping Slack, Tableau, MuleSoft, Data 360, and the newer Agentforce agentic layer around a subscription core. After two years of margin repair and share retirement, the company is now trying to prove that generative AI expands wallet share rather than cannibalizing seat-based licensing. Q2 FY27 delivered $11.35 billion in revenue, up 10.8% year over year, alongside non-GAAP EPS of $5.90 versus a $3.27 consensus, though roughly $2.53 of that came from strategic investment gains.
Why AI Monetization and Buybacks Justify Chasing the Rally
The bull case starts with cash generation. Free cash flow grew 81% year over year to $1.098 billion in the quarter, and management guides to a 34.3% non-GAAP operating margin for the year. The $25 billion accelerated repurchase has pulled diluted share count from 962 million to 821 million in twelve months.
AI monetization is no longer a slide-deck promise. Agentforce ARR crossed $1.5 billion, up over 240% year over year, and combined Agentforce and Data 360 ARR reached nearly $3.9 billion. On 15x forward earnings, that is a rare pairing of double-digit growth and defensive cash flow.
Where the Post-Earnings Surge Has Stretched the Setup
The bear case is that the easy repricing already happened. CRM ripped 38.87% in a single month, blowing through the $244.02 analyst consensus target. The EPS beat was optically enormous, but $2.61 billion in strategic investment gains did most of the heavy lifting, and GAAP operating income was essentially flat at negative 0.04% year over year.
Structural risks remain. Restructuring charges hit $94 million versus $4 million a year ago, shareholders’ equity fell 37.42%, and total liabilities nearly doubled to fund the ASR. Bears will also note that operating and free cash flow are only guided to grow 4% to 5% this year.
Case for Waiting Out the Post-Earnings Euphoria
The hold argument is timing. The business is executing, but the stock is pricing in flawless AI conversion. In 4 of the last 7 beats, CRM posted negative day-of reactions, and this quarter’s move is a three-sigma outlier against that pattern.
Patient investors can wait for Dreamforce Investor Day on September 16, 2026, the closings of Contentful and FEN, and the October 2026 final ASR settlement before adding aggressively. A retest of the $200.19 200-day moving average would offer a cleaner entry.
What Ratings, Targets, and Recent Returns Reveal
CRM trades at $252.05 against an average analyst target of $244.02, modestly above the consensus target. The Street breakdown across 55 analysts looks like this:
- Strong Buy: 5
- Buy: 35
- Hold: 13
- Sell: 0
- Strong Sell: 2
Targets are only one input, and most were set before the latest surge. CRM is down 4.36% year to date and up 1.62% over one year, badly trailing the S&P 500’s roughly double-digit YTD advance. Valuation screens reasonably at 15x forward earnings and a 0.85 PEG, with an EV/EBITDA of 15.
Verdict on Salesforce at $252
At $252.05, the setup for Salesforce skews constructive.
The path to appreciation runs through three catalysts: ClaudeForce general availability in September 2026, incremental revenue from Contentful and FEN closings, and continued Agentforce booking momentum that more than doubled quarter over quarter. With current RPO at $33.5 billion growing 14%, the revenue floor for FY27 and FY28 is well protected.
Risk/reward at 15x forward with a free-cash-flow machine profile and aggressive share retirement is asymmetric to the upside. Invalidation triggers: Agentforce ARR growth decelerating below 100% year over year, cRPO growth slipping into single digits, or operating margin guidance rolling back below 33%.
Scaling in incrementally looks more defensible than chasing the gap. Margin expansion, buyback support, and valuation multiple safety make CRM one of the cleanest AI-adjacent compounders for long-term portfolios, even after this move.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
